Indeed, non-governmental organizations, partnerships, and other diffusely held organizations have found that having too many stakeholders on a board can lead to gridlock.
"The huge benefit far outweighs the small patient numbers" whose tumors spread more diffusely on Avastin, says Duke University neuro-oncologist Henry S Friedman.